Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Preliminary clinical results for LMB-2

May 13, 1997

Trimidox enhances effects of doxorubicin in vivo

May 13, 1997

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

May 12, 1997

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

May 12, 1997

Retinoid-like compounds that induce apoptosis in cancer cells

May 12, 1997

Glycan-conjugated 5-FU for the treatment of hepatocellular cancer/metastases

May 12, 1997

Taiho discovers potent and selective cdc25PTP inhibitors

May 12, 1997

Parke-Davis develops new c-src TK inhibitors

May 12, 1997

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Schering-Plough evaluates novel farnesyltransferase inhibitor

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...